Review Article(s)
31 March 2021
Vol. 9 No. 1 (2021)
Review on the role of radiotherapy in oligometastatic prostate cancer castration-naive
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1204
Views
244
Downloads
Authors
In recent years, the treatment of metastatic cancer, either at diagnosis or relapsed after primary therapy, may be based not only on androgenic deprivation but other options should be considered as well. This is particularly relevant in the case known as “oligometastatic” that can be treated with curative intent. In such case Radiotherapy plays a paramount role for primary cancer control and the cure of the oligometastases.
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
Review on the role of radiotherapy in oligometastatic prostate cancer castration-naive. (2021). Working Paper of Public Health, 9(1). https://doi.org/10.4081/wpph.2021.9253
